Oto Smartphone App in Treating Tinnitus Amongst Adult Patients Compared with Standard Talking Therapies

ConditionTinnitus
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorEast and North Hertfordshire NHS Trust

About this trial

A study that looks at treating tinnitus and its associated burden, insomnia and quality of life effects with a smartphone app when compared with the talking therapies already offered on the national health service. Three separate questionnaires will be used to collect this data from patients at regular time intervals.

Eligibility criteria

Qualifiers

Adult patients (male or female) aged over 18 years of age presenting to NHS ENT and hearing services with primary non-pulsatile tinnitus irrespective of hearing.

Patients must be suffering from tinnitus for a minimum of 3 months

Patients that have a willingness to use as well as have access to a smartphone device capable of running Oto.

Willing and able to provide written informed consent.

Disqualifiers

Patients with secondary tinnitus as confirmed by magnetic resonance imaging (MRI).

Patients undergoing any other tinnitus therapies concurrently (including hearing aids / implants). Previous tinnitus therapies including CBT in the past are accepted.

Patients who are not willing to use the app due to not having a suitable phone to download the application or due to own limitations in working Oto.

Trial design

Treatments tested in this trial

  • Oto Smartphone Application (Oto Health Ltd)
  • Tinnitus Retraining Therapy (TRT)

Treatment groups

160 Participants
are divided into 2 treatment groups